Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre, shared a post on X/Twitter:
”James Buteau presenting on the prognostic role of post therapy SPECT/CT from 3 clinical trials of Lu-177 PSMA-617. New lesions conferred an unfavorable outcome, prognostic for survival. Great work from Raghava Kashyap and team of Prostate Cancer Theranostic and Imaging Centre.”
Source: Michael Hofman/X
